INCYTE AROUND THE WORLD
GLOBAL HEADQUARTERS
DENMARK
ITALY
PORTUGAL
UNITED KINGDOM
AUSTRIA
FINLAND
JAPAN
SPAIN
BELGIUM
FRANCE
THE NETHERLANDS
SWEDEN
CANADA
GERMANY
NORWAY
SWITZERLAND
Close
Incyte proudly adds VGA039 and theVIVID study to its hematology portfolio.
